Mariolitsa Mikellidi

Mariolitsa Mikellidi is a Risk Management Analyst at Oval Money since January 2022, responsible for defining and monitoring key risk indicators aligned with business objectives and managing dashboards and risk projects. Prior experience includes serving as a Product Manager in the Registration & Regulatory Affairs Department at Remedica Ltd, where risk assessments on product variations and new vendors were performed. Earlier roles include Auditor in the Assurance Department at KPMG, focusing on internal controls and financial statement reviews, and an Operations Assistant Intern at Galinos Medical Center, aiding in patient management and documentation. Mariolitsa has interned at The Cyprus Institute of Neurology & Genetics and is currently pursuing an MBA at the Cyprus International Institute of Management. Academic credentials include an MSc in Molecular Medicine and a BSc in Biomedical Science from the University of Sheffield, along with a high school education at Grammar School, Limassol.